Published in Int J Pharm on November 14, 2005
Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother (2006) 0.97
Transport of nanoparticles and tobramycin-loaded liposomes in Burkholderia cepacia complex biofilms. PLoS One (2013) 0.80
Activity and interactions of liposomal antibiotics in presence of polyanions and sputum of patients with cystic fibrosis. PLoS One (2009) 0.79
Efficacy of liposomal bismuth-ethanedithiol-loaded tobramycin after intratracheal administration in rats with pulmonary Pseudomonas aeruginosa infection. Antimicrob Agents Chemother (2012) 0.78
Efficacy and safety of liposomal clarithromycin and its effect on Pseudomonas aeruginosa virulence factors. Antimicrob Agents Chemother (2013) 0.77
Novel stable cytokine delivery system in physiological pH solution: chitosan oligosaccharide/heparin nanoparticles. Int J Nanomedicine (2015) 0.76
Pseudomonas aeruginosa-induced lung injury: role of oxidative stress. Microb Pathog (2002) 1.09
Importance of DNase and alginate lyase for enhancing free and liposome encapsulated aminoglycoside activity against Pseudomonas aeruginosa. J Antimicrob Chemother (2009) 1.06
Microscopical investigations of nisin-loaded nanoliposomes prepared by Mozafari method and their bacterial targeting. Micron (2007) 0.97
Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother (2006) 0.97
Antioxidants preserve macrophage phagocytosis of Pseudomonas aeruginosa during hyperoxia. Free Radic Biol Med (2007) 0.96
Liposome-mediated gentamicin delivery: development and activity against resistant strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients. J Antimicrob Chemother (2004) 0.94
Effectiveness of liposomal-N-acetylcysteine against LPS-induced lung injuries in rodents. Int J Pharm (2008) 0.93
Urokinase induces its own expression in Beas2B lung epithelial cells. Am J Physiol Lung Cell Mol Physiol (2002) 0.92
The effect of different lipid components on the in vitro stability and release kinetics of liposome formulations. Drug Deliv (2004) 0.90
Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains. Int J Pharm (2007) 0.87
Antimicrobial efficacy of a new antibiotic-loaded poly(hydroxybutyric-co-hydroxyvaleric acid) controlled release system. J Antimicrob Chemother (2004) 0.87
Inhibition of protein kinase C attenuates Pseudomonas aeruginosa elastase-induced epithelial barrier disruption. Am J Respir Cell Mol Biol (2011) 0.86
Effectiveness of liposomal paclitaxel against MCF-7 breast cancer cells. Can J Physiol Pharmacol (2010) 0.86
Intrapleural adenoviral delivery of human plasminogen activator inhibitor-1 exacerbates tetracycline-induced pleural injury in rabbits. Am J Respir Cell Mol Biol (2012) 0.85
Antibacterial activity of liposomal gentamicin against Pseudomonas aeruginosa: a time-kill study. Int J Antimicrob Agents (2006) 0.85
Bactericidal efficacy of liposomal aminoglycosides against Burkholderia cenocepacia. J Antimicrob Chemother (2007) 0.84
Liposomes as a carrier for gentamicin delivery: development and evaluation of the physicochemical properties. Int J Pharm (2008) 0.84
Therapeutic effect of liposomal-N-acetylcysteine against acetaminophen-induced hepatotoxicity. J Drug Target (2013) 0.83
Attenuation of Pseudomonas aeruginosa virulence factors and biofilms by co-encapsulation of bismuth-ethanedithiol with tobramycin in liposomes. J Antimicrob Chemother (2010) 0.83
Bismuth-thiol incorporation enhances biological activities of liposomal tobramycin against bacterial biofilm and quorum sensing molecules production by Pseudomonas aeruginosa. Int J Pharm (2009) 0.80
Importance of divalent cations in nanolipoplex gene delivery. J Pharm Sci (2007) 0.79
Activity and interactions of liposomal antibiotics in presence of polyanions and sputum of patients with cystic fibrosis. PLoS One (2009) 0.79
Safety of archaeosome adjuvants evaluated in a mouse model. J Liposome Res (2002) 0.79
Liposomal encapsulation of vancomycin improves killing of methicillin-resistant Staphylococcus aureus in a murine infection model. J Antimicrob Chemother (2012) 0.79
Characterization of human septic sera induced gene expression modulation in human myocytes. Int J Clin Exp Med (2009) 0.78
Liposomal antibiotics for the treatment of infectious diseases. Expert Opin Drug Deliv (2013) 0.78
Efficacy of liposomal bismuth-ethanedithiol-loaded tobramycin after intratracheal administration in rats with pulmonary Pseudomonas aeruginosa infection. Antimicrob Agents Chemother (2012) 0.78
Formulation and evaluation of floating tablet of H2-receptor antagonist. Drug Dev Ind Pharm (2015) 0.78
Hydrogen peroxide stress provokes a metabolic reprogramming in Pseudomonas fluorescens: enhanced production of pyruvate. J Biotechnol (2013) 0.78
Bismuth-ethanedithiol incorporated in a liposome-loaded tobramycin formulation modulates the alginate levels in mucoid Pseudomonas aeruginosa. J Pharm Pharmacol (2011) 0.78
Liposomal bismuth-ethanedithiol formulation enhances antimicrobial activity of tobramycin. Int J Pharm (2008) 0.77
Efficacy and safety of liposomal clarithromycin and its effect on Pseudomonas aeruginosa virulence factors. Antimicrob Agents Chemother (2013) 0.77
Nasal and pulmonary vaccine delivery using particulate carriers. Expert Opin Drug Deliv (2015) 0.77
Prophylactic effect of liposomal N-acetylcysteine against LPS-induced liver injuries. J Endotoxin Res (2007) 0.77
Ginseng aqueous extract attenuates the production of virulence factors, stimulates twitching and adhesion, and eradicates biofilms of Pseudomonas aeruginosa. Can J Physiol Pharmacol (2011) 0.76
The effect of aminoglycoside antibiotics on the thermodynamic properties of liposomal vesicles. J Liposome Res (2010) 0.76
Characterization of the interaction between liposomal formulations and Pseudomonas aeruginosa. J Liposome Res (2010) 0.76
Mechanism of fibroblast inflammatory responses to Pseudomonas aeruginosa elastase. Microbiology (2014) 0.76
Treatment of ricin A-chain-induced hepatotoxicity with liposome-encapsulated N-acetylcysteine. J Drug Target (2011) 0.75
Disposition of 3H-cholesteryl ether labeled liposomes following intravenous administration to mice: comparison with an encapsulated 14C-inulin as aqueous phase marker. Drug Deliv (2003) 0.75
Co-administration of aqueous ginseng extract with tobramycin stimulates the pro-inflammatory response and promotes the killing of Pseudomonas aeruginosa in the lungs of infected rats. Can J Physiol Pharmacol (2013) 0.75
Fumarate metabolism and ATP production in Pseudomonas fluorescens exposed to nitrosative stress. Antonie Van Leeuwenhoek (2014) 0.75
Correction: Identification and treatment of the Staphylococcus aureus reservoir in vivo. J Exp Med (2016) 0.75